These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6795680)

  • 1. [Biogenic amines and thyrotropin-releasing hormone (TRH) (author's transl)].
    Narumi S; Nagawa Y
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1702-7. PubMed ID: 6795680
    [No Abstract]   [Full Text] [Related]  

  • 2. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.
    Fornai F; Bassi L; Bonaccorsi I; Giorgi F; Corsini GU
    Funct Neurol; 1997; 12(3-4):193-8. PubMed ID: 9218976
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biogenic amines involved in hypothalamic control over the pituitary (author's transl)].
    Uemura H; Kobayashi H
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1690-701. PubMed ID: 7029635
    [No Abstract]   [Full Text] [Related]  

  • 5. [TRH (author's transl)].
    Mistsuma T
    Nihon Rinsho; 1978; 36(1):125-9. PubMed ID: 416248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphine-like peptides and dopaminergic pathways].
    Destee A
    LARC Med; 1981 Dec; 1(3):53-4, 57-8. PubMed ID: 6298510
    [No Abstract]   [Full Text] [Related]  

  • 7. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
    Fuxe K; Hökfelt T; Olson L; Ungerstedt U
    Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible interaction between cholecystokinin and dopamine.
    Govoni S; Yang HY; Bosio A; Pasinetti G; Costa E
    Adv Biochem Psychopharmacol; 1982; 33():437-44. PubMed ID: 7124508
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.
    Kirik D; Rosenblad C; Björklund A
    Exp Neurol; 1998 Aug; 152(2):259-77. PubMed ID: 9710526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.
    Moore RY; Bloom FE
    Annu Rev Neurosci; 1978; 1():129-69. PubMed ID: 756202
    [No Abstract]   [Full Text] [Related]  

  • 11. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra.
    Stanic D; Tripanichkul W; Drago J; Finkelstein DI; Horne MK
    Brain Res; 2004 Oct; 1023(1):83-91. PubMed ID: 15364022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined behavioral and morphological study on the effects of fetal asphyxia on the nigrostriatal dopaminergic system in adult rats.
    Strackx E; Van den Hove DL; Steinbusch HP; Steinbusch HW; Vles JS; Blanco CE; Gavilanes AW
    Exp Neurol; 2008 Jun; 211(2):413-22. PubMed ID: 18402938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Substance P and biogenic monoamines (author's transl)].
    Kato T
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1680-9. PubMed ID: 6171013
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nerve endings and pharmacological receptors in cerebral vessels (author's transl)].
    Marín PJ
    Arch Farmacol Toxicol; 1980 Dec; 6(3):189-208. PubMed ID: 6118101
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopaminergic nigrostriatal system: development, physiology, disease.
    von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
    [No Abstract]   [Full Text] [Related]  

  • 17. Circling behavior produced by unilateral lesions of the central vestibular system.
    Shima F; Hassler R
    Appl Neurophysiol; 1982; 45(3):255-60. PubMed ID: 7059159
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of midbrain reticular formation in the expression of dopamine-mediated circling behaviour.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1981; 30():187-204. PubMed ID: 6800220
    [No Abstract]   [Full Text] [Related]  

  • 20. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.
    Thompson LH; Grealish S; Kirik D; Björklund A
    Eur J Neurosci; 2009 Aug; 30(4):625-38. PubMed ID: 19674082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.